Yatin Suneja
Stock Analyst at Guggenheim
(4.49)
# 288
Out of 5,055 analysts
146
Total ratings
58.46%
Success rate
17.33%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IFRX InflaRx | Maintains: Buy | $10 → $22 | $1.35 | +1,529.63% | 6 | Nov 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $100 | $33.82 | +195.68% | 14 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $200 → $205 | $139.69 | +46.75% | 9 | Nov 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $815 → $865 | $693.50 | +24.73% | 8 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Buy | $14 | $2.65 | +428.30% | 3 | Oct 27, 2025 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $70 | $28.85 | +142.63% | 4 | Oct 27, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $60 | $27.08 | +121.57% | 1 | Oct 27, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $350 | $186.42 | +87.75% | 3 | Oct 17, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $101 → $150 | $110.39 | +35.88% | 3 | Oct 10, 2025 | |
| ACET Adicet Bio | Maintains: Buy | $7 → $8 | $0.66 | +1,107.91% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $12.77 | +56.62% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $907.98 | +17.84% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $21 | $20.29 | +3.50% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $40.85 | +144.80% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $14.38 | +421.56% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.31 | +549.35% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $144.86 | +20.81% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.38 | +669.23% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $18 | $5.52 | +226.09% | 2 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $14.00 | +107.14% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $14.56 | -17.58% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.08 | +267.65% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $23.74 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $35.00 | +28.57% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $12.98 | +246.69% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $24.02 | -16.74% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.16 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $23.50 | +176.60% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $25.55 | +252.25% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $40.76 | +20.22% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $11.59 | +374.75% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $167.55 | +108.89% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.95 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.60 | +53.85% | 1 | May 31, 2022 |
InflaRx
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $1.35
Upside: +1,529.63%
AnaptysBio
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $33.82
Upside: +195.68%
Axsome Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $139.69
Upside: +46.75%
Regeneron Pharmaceuticals
Oct 29, 2025
Maintains: Buy
Price Target: $815 → $865
Current: $693.50
Upside: +24.73%
Neumora Therapeutics
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $2.65
Upside: +428.30%
RAPT Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $28.85
Upside: +142.63%
Oruka Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $27.08
Upside: +121.57%
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $155 → $350
Current: $186.42
Upside: +87.75%
ABIVAX Société Anonyme
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $110.39
Upside: +35.88%
Adicet Bio
Oct 8, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $0.66
Upside: +1,107.91%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $12.77
Upside: +56.62%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $907.98
Upside: +17.84%
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $20.29
Upside: +3.50%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $40.85
Upside: +144.80%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $14.38
Upside: +421.56%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.31
Upside: +549.35%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $144.86
Upside: +20.81%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.38
Upside: +669.23%
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $5.52
Upside: +226.09%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $14.00
Upside: +107.14%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $14.56
Upside: -17.58%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $4.08
Upside: +267.65%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $23.74
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $35.00
Upside: +28.57%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $12.98
Upside: +246.69%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $24.02
Upside: -16.74%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.16
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $23.50
Upside: +176.60%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $25.55
Upside: +252.25%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $40.76
Upside: +20.22%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $11.59
Upside: +374.75%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $167.55
Upside: +108.89%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.95
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.60
Upside: +53.85%